We are live on ! Find out more
CHRS icon

Coherus Oncology
CHRS

51 hedge funds and large institutions have $222M invested in Coherus Oncology in 2015 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

118% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 11

41% more capital invested

Capital invested by funds: $158M → $222M (+$64M)

34% more funds holding

Funds holding: 38 → 51 (+13)

18% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 11

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
51
Holders Change
+13
Holders Change %
+34.21%
% of All Funds
1.36%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
24
Increased
13
Reduced
11
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$14.2M
2
Millennium Management
Millennium Management
New York
+$7.26M
3
CCI
Columbus Circle Investors
+$5.71M
4
HCMT
Highland Capital Management (Texas)
Texas
+$4.21M
5
EI
EAM Investors
California
+$4.2M

Top Sellers

Rank Fund Capital Flow
1
KKRC
Kohlberg Kravis Roberts & Co
New York
-$49.9M
2
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$12.7M
3
PA
Perceptive Advisors
New York
-$9.12M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$9.09M
5
Morgan Stanley
Morgan Stanley
New York
-$1.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$47.6M – – –
JP Morgan Chase
2
JP Morgan Chase
New York
$39.3M +$14.2M +549,384 +75%
VM
3
VHCP Management
New York
$26M – – –
Fidelity Investments
4
Fidelity Investments
Massachusetts
$25.5M -$9.09M -351,900 -30%
Millennium Management
5
Millennium Management
New York
$8.59M +$7.26M +280,999 New
Brown Advisory
6
Brown Advisory
Maryland
$6.77M -$61.7K -2,387 -1%
CCI
7
Columbus Circle Investors
$6.75M +$5.71M +220,825 New
CAM
8
Cormorant Asset Management
Massachusetts
$6.7M -$79.3K -3,070 -1%
RSCM
9
Rock Springs Capital Management
Maryland
$6.09M -$1.06M -41,000 -17%
Vanguard Group
10
Vanguard Group
Pennsylvania
$5.37M +$2.68M +103,861 +145%
HCMT
11
Highland Capital Management (Texas)
Texas
$4.99M +$4.21M +163,044 New
EI
12
EAM Investors
California
$4.97M +$4.2M +162,485 New
MIM
13
Monashee Investment Management
Massachusetts
$3.06M +$2.58M +100,000 New
Northern Trust
14
Northern Trust
Illinois
$2.75M +$520K +20,109 +29%
PA
15
Perceptive Advisors
New York
$2.61M -$9.12M -352,712 -81%
State Street
16
State Street
Massachusetts
$2.47M +$1.24M +47,929 +146%
BAMS
17
Bellevue Asset Management (Switzerland)
Switzerland
$2.45M +$2.07M +80,000 New
RFC
18
Russell Frank Company
Washington
$2.35M +$1.99M +76,820 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$1.88M +$632K +24,466 +66%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$1.74M +$1.04M +40,073 +239%
TCIM
21
TIAA CREF Investment Management
New York
$1.72M +$1.41M +54,595 +3,585%
PAM
22
Panagora Asset Management
Massachusetts
$1.64M +$635K +24,566 +84%
TCP
23
Tourbillon Capital Partners
New York
$1.53M +$1.29M +50,000 New
Ameriprise
24
Ameriprise
Minnesota
$1.23M +$1.04M +40,225 New
CS
25
Candriam SCA
Luxembourg
$1.22M +$1.03M +40,000 New
1
2 3

CHRS Hedge Fund Activity: Q1 2015 in Review

51 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q1 2015, worth a combined $222M — up 41% from $158M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new CHRS positions and 11 closed out — a net gain of 13 holders — while 13 added to existing stakes and 11 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $14.2M. The largest seller was Kohlberg Kravis Roberts & Co, exiting entirely with an estimated $49.9M sold.

  • 51 institutional investors held Coherus Oncology (CHRS) as of Q1 2015, up from 38 in Q4 2014.
  • Funds reported $222M of Coherus Oncology stock for Q1 2015, up 41% quarter-over-quarter.
  • 24 funds opened new Coherus Oncology positions in Q1 2015 and 11 closed out, a net change of +13 holders.
  • The largest Coherus Oncology buyer in Q1 2015 was JP Morgan Chase, an estimated $14.2M added.
  • The largest Coherus Oncology seller in Q1 2015 was Kohlberg Kravis Roberts & Co, an estimated $49.9M sold.

Based on aggregated 13F filings for Q1 2015.